Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bromide, Propantheline
2. Pro Banthine
3. Pro-banthine
4. Probanthine
5. Propantheline
1. 50-34-0
2. Pro-banthine
3. Propantheline (bromide)
4. Neometantyl
5. Neopepulsan
6. (2-hydroxyethyl)diisopropylmethylammonium Bromide Xanthene-9-carboxylate
7. Nsc-757294
8. Mls000028703
9. Ux9z118x9f
10. 2-propanaminium, N-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)-, Bromide
11. Ncgc00094306-02
12. Smr000058661
13. Dsstox_cid_3519
14. Dsstox_rid_77062
15. Dsstox_gsid_23519
16. Ccris 6271
17. Nci-c56257
18. Cas-50-34-0
19. Sr-01000003171
20. Propanthelini Bromidum [inn-latin]
21. Einecs 200-030-6
22. Bromuro De Proantelina [inn-spanish]
23. Bromure De Propantheline [inn-french]
24. Sc-3171
25. Unii-ux9z118x9f
26. N-(2-(9h-xanthene-9-carbonyloxy)ethyl)-n-isopropyl-n-methylpropan-2-aminium Bromide
27. Propantheline,(s)
28. N-methyl-n-(1-methylethyl)-n-{2-[(9h-xanthen-9-ylcarbonyl)oxy]ethyl}propan-2-aminium Bromide
29. Prestwick_241
30. Mfcd00050291
31. Propantheline Bromide [usp:inn:ban:jan]
32. Opera_id_1667
33. Diisopropyl(2-hydroxyethyl)methylammonium Bromide Xanthene-9-carboxylate
34. Chembl1240
35. Xanthene-9-carboxylic Acid, Ester With (2-hydroxyethyl)diisopropylmethylammonium Bromide
36. Regid_for_cid_9279
37. Schembl40291
38. Mls001076547
39. Mls001333690
40. Spectrum1500511
41. Chebi:8482
42. Dtxsid2023519
43. Hms502i04
44. Hms1570f15
45. Hms1920l18
46. Hms2092c19
47. Hms2097f15
48. Hms2234m23
49. Hms3259e04
50. Hms3263k09
51. Hms3370n21
52. Hms3714f15
53. Hms3886k03
54. Pharmakon1600-01500511
55. Propantheline Bromide [mi]
56. Propantheline Bromide [inn]
57. Propantheline Bromide [jan]
58. Hy-b1188
59. Tox21_111265
60. Tox21_302331
61. Tox21_501014
62. Ccg-39238
63. Nsc757294
64. Propantheline Bromide [mart.]
65. Akos015895527
66. Ammonium, Diisopropyl(2-hydroxyethyl)methyl-, Bromide, Xanthene-9-carboxylate
67. Propantheline Bromide [usp-rs]
68. Propantheline Bromide [who-dd]
69. Tox21_111265_1
70. Cs-4797
71. Ks-1386
72. Lp01014
73. Nc00529
74. Nsc 757294
75. Propantheline Bromide (jp17/usp/inn)
76. Ncgc00015854-10
77. Ncgc00094306-01
78. Ncgc00094306-03
79. Ncgc00094306-04
80. Ncgc00094306-05
81. Ncgc00255145-01
82. Ncgc00261699-01
83. 2-propanaminium,n-methyl-n-(1-methylethyl)-n-[2-[(9h-xanthen-9-ylcarbonyl)oxy]ethyl]-,bromide
84. Ac-13428
85. Propantheline Bromide [ep Impurity]
86. Propantheline Bromide [orange Book]
87. Db-051756
88. Propantheline Bromide [usp Impurity]
89. Eu-0101014
90. Ft-0603218
91. Propantheline Bromide [usp Monograph]
92. Propantheline Bromide, >=97% (tlc), Powder
93. D00481
94. D82053
95. P 8891
96. A828073
97. Sr-01000003171-2
98. Sr-01000003171-4
99. Sr-01000003171-7
100. W-105970
101. Q27291318
102. Propantheline Bromide, United States Pharmacopeia (usp) Reference Standard
103. (2-hydroxyethyl)diisopropylmethylammonium Bromide Xanthene-9-carboxylate Bromide
104. Methyl-[2-[oxo(9h-xanthen-9-yl)methoxy]ethyl]-di(propan-2-yl)ammonium Bromide
105. Methyl-di(propan-2-yl)-[2-(9h-xanthen-9-ylcarbonyloxy)ethyl]azanium Bromide
106. Propantheline Bromide, Pharmaceutical Secondary Standard; Certified Reference Material
107. 2-propanaminium, N-methyl-n-(1-methylethyl)-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)-, Bromide (1:1)
108. N-isopropyl-n-methyl-n-(2-((9h-xanthen-9-ylcarbonyl)oxy)ethyl)propan-2-aminium Bromide
Molecular Weight | 448.4 g/mol |
---|---|
Molecular Formula | C23H30BrNO3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 447.14091 g/mol |
Monoisotopic Mass | 447.14091 g/mol |
Topological Polar Surface Area | 35.5 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 474 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Propantheline bromide |
Drug Label | Each tablet for oral administration contains:Propantheline bromide.................................................. 15 mgPropantheline bromide, a synthetic quaternary ammonium compound, occurs as white or nearly white crystals. It is odorless and ha... |
Active Ingredient | Propantheline bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 15mg |
Market Status | Prescription |
Company | Roxane |
2 of 2 | |
---|---|
Drug Name | Propantheline bromide |
Drug Label | Each tablet for oral administration contains:Propantheline bromide.................................................. 15 mgPropantheline bromide, a synthetic quaternary ammonium compound, occurs as white or nearly white crystals. It is odorless and ha... |
Active Ingredient | Propantheline bromide |
Dosage Form | Tablet |
Route | Oral |
Strength | 15mg |
Market Status | Prescription |
Company | Roxane |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Propantheline Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Propantheline Bromide, including repackagers and relabelers. The FDA regulates Propantheline Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Propantheline Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Propantheline Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Propantheline Bromide supplier is an individual or a company that provides Propantheline Bromide active pharmaceutical ingredient (API) or Propantheline Bromide finished formulations upon request. The Propantheline Bromide suppliers may include Propantheline Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Propantheline Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Propantheline Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Propantheline Bromide active pharmaceutical ingredient (API) in detail. Different forms of Propantheline Bromide DMFs exist exist since differing nations have different regulations, such as Propantheline Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Propantheline Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Propantheline Bromide USDMF includes data on Propantheline Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Propantheline Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Propantheline Bromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Propantheline Bromide Drug Master File in Japan (Propantheline Bromide JDMF) empowers Propantheline Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Propantheline Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Propantheline Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Propantheline Bromide suppliers with JDMF on PharmaCompass.
A Propantheline Bromide written confirmation (Propantheline Bromide WC) is an official document issued by a regulatory agency to a Propantheline Bromide manufacturer, verifying that the manufacturing facility of a Propantheline Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Propantheline Bromide APIs or Propantheline Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Propantheline Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Propantheline Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Propantheline Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Propantheline Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Propantheline Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Propantheline Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Propantheline Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Propantheline Bromide suppliers with NDC on PharmaCompass.
Propantheline Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Propantheline Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Propantheline Bromide GMP manufacturer or Propantheline Bromide GMP API supplier for your needs.
A Propantheline Bromide CoA (Certificate of Analysis) is a formal document that attests to Propantheline Bromide's compliance with Propantheline Bromide specifications and serves as a tool for batch-level quality control.
Propantheline Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Propantheline Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Propantheline Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Propantheline Bromide EP), Propantheline Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Propantheline Bromide USP).
LOOKING FOR A SUPPLIER?